Nshogozabahizi, J. C., Aubrey, K. L., Ross, J. A. & Thakor, N. Applications and limitations of regulatory RNA elements in synthetic biology and biotechnology. J. Appl. Microbiol. 127, 968–984 (2019).
Google Scholar
Kim, J. & Franco, E. RNA nanotechnology in synthetic biology. Curr. Opin. Biotechnol. 63, 135–141 (2020).
Google Scholar
Schmidt, C. M. & Smolke, C. D. RNA switches for synthetic biology. Cold Spring Harb. Perspect. Biol. 11, 135–141 (2019).
Park, S. V. et al. Catalytic RNA, ribozyme, and its applications in synthetic biology. Biotechnol. Adv. 37, 107452 (2019).
Google Scholar
Win, M. N., Liang, J. C. & Smolke, C. D. Frameworks for programming biological function through RNA parts and devices. Chem. Biol. 16, 298–310 (2009).
Google Scholar
Liang, J. C., Bloom, R. J. & Smolke, C. D. Engineering biological systems with synthetic RNA molecules. Mol. Cell 43, 915–926 (2011).
Google Scholar
Nahvi, A. et al. Genetic control by a metabolite binding mRNA. Chem. Biol. 9, 1043–1049 (2002).
Google Scholar
Winkler, W. C., Cohen-Chalamish, S. & Breaker, R. R. An mRNA structure that controls gene expression by binding FMN. Proc. Natl Acad. Sci. USA 99, 15908–15913 (2002).
Google Scholar
Sudarsan, N., Barrick, J. E. & Breaker, R. R. Metabolite-binding RNA domains are present in the genes of eukaryotes. RNA 9, 644–647 (2003).
Google Scholar
Isaacs, F. J. et al. Engineered riboregulators enable post-transcriptional control of gene expression. Nat. Biotechnol. 22, 841–847 (2004).
Google Scholar
Suess, B. & Weigand, J. E. Engineered riboswitches: overview, problems and trends. RNA Biol. 5, 24–29 (2008).
Google Scholar
McKeague, M., Wong, R. S. & Smolke, C. D. Opportunities in the design and application of RNA for gene expression control. Nucleic Acids Res. 44, 2987–2999 (2016).
Google Scholar
Westbrook, A. M. & Lucks, J. B. Achieving large dynamic range control of gene expression with a compact RNA transcription–translation regulator. Nucleic Acids Res. 45, 5614–5624 (2017).
Google Scholar
Kim, J. et al. De novo-designed translation-repressing riboregulators for multi-input cellular logic. Nat. Chem. Biol. 15, 1173–1182 (2019).
Google Scholar
Rauch, S., Jones, K. A. & Dickinson, B. C. Small molecule-inducible RNA-targeting systems for temporal control of RNA regulation. ACS Cent. Sci. 6, 1987–1996 (2020).
Google Scholar
Chappell, J., Westbrook, A., Verosloff, M. & Lucks, J. B. Computational design of small transcription activating RNAs for versatile and dynamic gene regulation. Nat. Commun. 8, 1051 (2017).
Google Scholar
Anzalone, A. V., Lin, A. J., Zairis, S., Rabadan, R. & Cornish, V. W. Reprogramming eukaryotic translation with ligand-responsive synthetic RNA switches. Nat. Methods 13, 453–458 (2016).
Google Scholar
Spöring, M., Finke, M. & Hartig, J. S. Aptamers in RNA-based switches of gene expression. Curr. Opin. Biotechnol. 63, 34–40 (2020).
Google Scholar
Kawasaki, S., Ono, H., Hirosawa, M. & Saito, H. RNA and protein-based nanodevices for mammalian post-transcriptional circuits. Curr. Opin. Biotechnol. 63, 99–110 (2020).
Google Scholar
Endy, D. Foundations for engineering biology. Nature 438, 449–453 (2005).
Google Scholar
Barrick, J. E. & Breaker, R. R. The distributions, mechanisms, and structures of metabolite-binding riboswitches. Genome Biol. 8, R239 (2007).
Google Scholar
Ellington, A. D. & Szostak, J. W. In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818–822 (1990).
Google Scholar
Lauridsen, L. H., Doessing, H. B., Long, K. S. & Nielsen, A. T. in Synthetic Metabolic Pathways: Methods and Protocols (eds. Jensen, M. K. & Keasling, J. D.) 291–306 (Springer, 2018).
Baird, G. S. Where are all the aptamers? Am. J. Clin. Pathol. 134, 529–531 (2010).
Google Scholar
Dunn, M. R., Jimenez, R. M. & Chaput, J. C. Analysis of aptamer discovery and technology. Nat. Rev. Chem. 1, 0076 (2017).
Google Scholar
McKeague, M. & DeRosa, M. C. Challenges and opportunities for small molecule aptamer development. J. Nucleic Acids 2012, 1–20 (2012).
McKeague, M. et al. Analysis of in vitro aptamer selection parameters. J. Mol. Evol. 81, 150–161 (2015).
Google Scholar
Valencia-Sanchez, M. A., Liu, J., Hannon, G. J. & Parker, R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 20, 515–524 (2006).
Google Scholar
Bloom, R. J., Winkler, S. M. & Smolke, C. D. Synthetic feedback control using an RNAi-based gene-regulatory device. J. Biol. Eng. 9, 5 (2015).
Google Scholar
Lucks, J. B., Qi, L., Mutalik, V. K., Wang, D. & Arkin, A. P. Versatile RNA-sensing transcriptional regulators for engineering genetic networks. Proc. Natl Acad. Sci. USA 108, 8617–8622 (2011).
Google Scholar
Ausländer, S. & Fussenegger, M. Synthetic RNA-based switches for mammalian gene expression control. Curr. Opin. Biotechnol. 48, 54–60 (2017).
Google Scholar
Chappell, J. et al. The centrality of RNA for engineering gene expression. Biotechnol. J. 8, 1379–1395 (2013).
Google Scholar
Till, P., Toepel, J., Bühler, B., Mach, R. L. & Mach-Aigner, A. R. Regulatory systems for gene expression control in cyanobacteria. Appl. Microbiol. Biotechnol. 104, 1977–1991 (2020).
Google Scholar
Bayer, T. S. & Smolke, C. D. Programmable ligand-controlled riboregulators of eukaryotic gene expression. Nat. Biotechnol. 23, 337–343 (2005).
Google Scholar
Kawasaki, S., Fujita, Y., Nagaike, T., Tomita, K. & Saito, H. Synthetic mRNA devices that detect endogenous proteins and distinguish mammalian cells. Nucleic Acids Res. 45, e117–e117 (2017).
Google Scholar
Paige, J. S., Nguyen-Duc, T., Song, W. & Jaffrey, S. R. Fluorescence imaging of cellular metabolites with RNA. Science 335, 1194–1194 (2012).
Google Scholar
Jepsen, M. D. E. et al. Development of a genetically encodable FRET system using fluorescent RNA aptamers. Nat. Commun. 9, 18 (2018).
Google Scholar
Wurmthaler, L. A., Sack, M., Gense, K., Hartig, J. S. & Gamerdinger, M. A tetracycline-dependent ribozyme switch allows conditional induction of gene expression in Caenorhabditis elegans. Nat. Commun. 10, 491 (2019).
Google Scholar
Gu, H., Furukawa, K. & Breaker, R. R. Engineered allosteric ribozymes that sense the bacterial second messenger cyclic diguanosyl 5′-monophosphate. Anal. Chem. 84, 4935–4941 (2012).
Google Scholar
Niu, T. et al. Engineering a glucosamine-6-phosphate responsive glmS ribozyme switch enables dynamic control of metabolic flux in Bacillus subtilis for overproduction of N-acetylglucosamine. ACS Synth. Biol. 7, 2423–2435 (2018).
Google Scholar
Sterner, R. C. & Sterner, R. M. CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J. 11, 1–11 (2021).
Di Stasi, A. et al. Inducible apoptosis as a safety switch for adoptive cell therapy. N. Engl. J. Med. 365, 1673–1683 (2011).
Google Scholar
Chen, Y. Y., Jensen, M. C. & Smolke, C. D. Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems. Proc. Natl Acad. Sci. USA 107, 8531–8536 (2010).
Google Scholar
Wong, R. S., Chen, Y. Y. & Smolke, C. D. Regulation of T cell proliferation with drug-responsive microRNA switches. Nucleic Acids Res. 46, 1541–1552 (2018).
Google Scholar
Liu, Y. et al. Directing cellular information flow via CRISPR signal conductors. Nat. Methods 13, 938–944 (2016).
Google Scholar
Liu, Y. et al. Engineering cell signaling using tunable CRISPR–Cpf1-based transcription factors. Nat. Commun. 8, 2095 (2017).
Google Scholar
Tang, W., Hu, J. H. & Liu, D. R. Aptazyme-embedded guide RNAs enable ligand-responsive genome editing and transcriptional activation. Nat. Commun. 8, 15939 (2017).
Google Scholar
Hoffmann, M. D. et al. Cell-specific CRISPR–Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins. Nucleic Acids Res. 47, e75 (2019).
Google Scholar
Hirosawa, M. et al. Cell-type-specific genome editing with a microRNA-responsive CRISPR–Cas9 switch. Nucleic Acids Res. 45, e118 (2017).
Google Scholar
Hirosawa, M., Fujita, Y. & Saito, H. Cell-type-specific CRISPR activation with microRNA-responsive AcrllA4 switch. ACS Synth. Biol. 8, 1575–1582 (2019).
Google Scholar
Lee, J. et al. Tissue-restricted genome editing in vivo specified by microRNA-repressible anti-CRISPR proteins. RNA 25, 1421–1431 (2019).
Google Scholar
Davis, K. M., Pattanayak, V., Thompson, D. B., Zuris, J. A. & Liu, D. R. Small molecule-triggered Cas9 protein with improved genome-editing specificity. Nat. Chem. Biol. 11, 316–318 (2015).
Google Scholar
Robbins, P. D., Tahara, H. & Ghivizzani, S. C. Viral vectors for gene therapy. Trends Biotechnol. 16, 35–40 (1998).
Google Scholar
Strobel, B. et al. Riboswitch-mediated attenuation of transgene cytotoxicity increases adeno-associated virus vector yields in HEK-293 cells. Mol. Ther. 23, 1582–1591 (2015).
Google Scholar
Takahashi, K. & Yokobayashi, Y. Reversible gene regulation in mammalian cells using riboswitch-engineered vesicular stomatitis virus vector. ACS Synth. Biol. 8, 1976–1982 (2019).
Google Scholar
Reid, C. A., Nettesheim, E. R., Connor, T. B. & Lipinski, D. M. Development of an inducible anti-VEGF rAAV gene therapy strategy for the treatment of wet AMD. Sci. Rep. 8, 11763 (2018).
Google Scholar
Strobel, B. et al. A small-molecule-responsive riboswitch enables conditional induction of viral vector-mediated gene expression in mice. ACS Synth. Biol. 9, 1292–1305 (2020).
Google Scholar
Han, S. R. et al. Targeted suicide gene therapy for liver cancer based on ribozyme-mediated RNA replacement through post-transcriptional regulation. Mol. Ther. Nucleic Acids 23, 154–168 (2021).
Google Scholar
Wang, H. et al. Characterization of a bifunctional synthetic RNA aptamer and a truncated form for ability to inhibit growth of non-small cell lung cancer. Sci. Rep. 9, 18836 (2019).
Google Scholar
Worgall, S., Wolff, G., Falck-Pedersen, E. & Crystal, R. G. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther. 8, 37–44 (1997).
Google Scholar
Uehata, T. & Takeuchi, O. RNA recognition and immunity-innate immune sensing and its posttranscriptional regulation mechanisms. Cells 9, E1701 (2020).
Google Scholar
Ireton, R. C., Wilkins, C. & Gale, M. RNA PAMPs as molecular tools for evaluating RIG-I function in innate immunity. Methods Mol. Biol. 1656, 119–129 (2017).
Google Scholar
Kell, A. M. & Gale, M. RIG-I in RNA virus recognition. Virology 479–480, 110–121 (2015).
Google Scholar
Wu, M. Z., Asahara, H., Tzertzinis, G. & Roy, B. Synthesis of low immunogenicity RNA with high-temperature in vitro transcription. RNA 26, 345–360 (2020).
Google Scholar
Andries, O. et al. N1-Methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice. J. Control. Rel. 217, 337–344 (2015).
Google Scholar
Karikó, K. et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol. Ther. 16, 1833–1840 (2008).
Google Scholar
Wesselhoeft, R. A. et al. RNA circularization diminishes immunogenicity and can extend translation duration in vivo. Mol. Cell 74, 508–520.e4 (2019).
Google Scholar
Pardi, N., Hogan, M. J. & Weissman, D. Recent advances in mRNA vaccine technology. Curr. Opin. Immunol. 65, 14–20 (2020).
Google Scholar
Wadhwa, A., Aljabbari, A., Lokras, A., Foged, C. & Thakur, A. Opportunities and challenges in the delivery of mRNA-based vaccines. Pharmaceutics 12, E102 (2020).
Google Scholar
Dua, P., Kim, S. & Lee, D. Nucleic acid aptamers targeting cell-surface proteins. Methods 54, 215–225 (2011).
Google Scholar
Narberhaus, F., Waldminghaus, T. & Chowdhury, S. RNA thermometers. FEMS Microbiol. Rev. 30, 3–16 (2006).
Google Scholar
Neupert, J., Karcher, D. & Bock, R. Design of simple synthetic RNA thermometers for temperature-controlled gene expression in Escherichia coli. Nucleic Acids Res. 36, e124–e124 (2008).
Google Scholar
Lotz, T. S. et al. A light-responsive RNA aptamer for an azobenzene derivative. Nucleic Acids Res. 47, 2029–2040 (2019).
Google Scholar
Gold, L. et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE 5, e15004 (2010).
Google Scholar
Darmostuk, M., Rimpelova, S., Gbelcova, H. & Ruml, T. Current approaches in SELEX: an update to aptamer selection technology. Biotechnol. Adv. 33, 1141–1161 (2015).
Google Scholar
Wayment-Steele, H., Wu, M., Gotrik, M. & Das, R. in Methods in Enzymology Vol. 623 Ch. 18 (ed. Hargrove, A. E.) 417–450 (Academic, 2019).
Davis, J. H. & Szostak, J. W. Isolation of high-affinity GTP aptamers from partially structured RNA libraries. Proc. Natl Acad. Sci. USA 99, 11616–11621 (2002).
Google Scholar
Kohlberger, M. & Gadermaier, G. SELEX: critical factors and optimization strategies for successful aptamer selection. Biotechnol. Appl. Biochem. https://doi.org/10.1002/bab.2244 (2021).
Google Scholar
Komarova, N. & Kuznetsov, A. Inside the black box: what makes SELEX better? Molecules 24, E3598 (2019).
Google Scholar
Ricci, F., Vallée-Bélisle, A., Simon, A. J., Porchetta, A. & Plaxco, K. W. Using nature’s “tricks” to rationally tune the binding properties of biomolecular receptors. Acc. Chem. Res. 49, 1884–1892 (2016).
Google Scholar
Townshend, B., Xiang, J. S., Manzanarez, G., Hayden, E. J. & Smolke, C. D. A multiplexed, automated evolution pipeline enables scalable discovery and characterization of biosensors. Nat. Commun. 12, 1437 (2021).
Google Scholar
Hasegawa, H., Savory, N., Abe, K. & Ikebukuro, K. Methods for improving aptamer binding affinity. Molecules 21, 421 (2016).
Google Scholar
Kalra, P., Dhiman, A., Cho, W. C., Bruno, J. G. & Sharma, T. K. Simple methods and rational design for enhancing aptamer sensitivity and specificity. Front. Mol. Biosci. 5, 41 (2018).
Google Scholar
Stoltenburg, R., Nikolaus, N. & Strehlitz, B. Capture-SELEX: selection of DNA aptamers for aminoglycoside antibiotics. J. Anal. Methods Chem. 2012, 1–14 (2012).
Boussebayle, A., Groher, F. & Suess, B. RNA-based Capture-SELEX for the selection of small molecule-binding aptamers. Methods 161, 10–15 (2019).
Google Scholar
Koizumi, M., Soukup, G. A., Kerr, J. N. & Breaker, R. R. Allosteric selection of ribozymes that respond to the second messengers cGMP and cAMP. Nat. Struct. Biol. 6, 1062–1071 (1999).
Google Scholar
Xiang, J. S. et al. Massively parallel RNA device engineering in mammalian cells with RNA-seq. Nat. Commun. 10, 4327 (2019).
Google Scholar
Strobel, B. et al. High-throughput identification of synthetic riboswitches by barcode-free amplicon-sequencing in human cells. Nat. Commun. 11, 1–12 (2020).
Townshend, B., Kennedy, A. B., Xiang, J. S. & Smolke, C. D. High-throughput cellular RNA device engineering. Nat. Methods 12, 989–994 (2015).
Google Scholar
Nomura, Y., Chien, H.-C. & Yokobayashi, Y. Direct screening for ribozyme activity in mammalian cells. Chem. Commun. 53, 12540–12543 (2017).
Google Scholar
Gotrik, M. et al. Direct selection of fluorescence-enhancing RNA aptamers. J. Am. Chem. Soc. 140, 3583–3591 (2018).
Google Scholar
Zhao, B. S., Roundtree, I. A. & He, C. Post-transcriptional gene regulation by mRNA modifications. Nat. Rev. Mol. Cell Biol. 18, 31–42 (2017).
Google Scholar
Holley, R. W., Everett, G. A., Madison, J. T. & Zamir, A. Nucleotide sequences in the yeast alanine transfer ribonucleic acid. J. Biol. Chem. 240, 2122–2128 (1965).
Google Scholar
Pereira, M. et al. Impact of tRNA modifications and tRNA-modifying enzymes on proteostasis and human disease. Int. J. Mol. Sci. 19, E3738 (2018).
Google Scholar
Dominissini, D. et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature 485, 201–206 (2012).
Google Scholar
Meyer, K. D. et al. Comprehensive analysis of mRNA methylation reveals enrichment in 3′ UTRs and near stop codons. Cell 149, 1635–1646 (2012).
Google Scholar
Jaffrey, S. R. & Kharas, M. G. Emerging links between m6A and misregulated mRNA methylation in cancer. Genome Med. 9, 2 (2017).
Google Scholar
Liu, J. et al. A METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat. Chem. Biol. 10, 93–95 (2014).
Google Scholar
Wilson, C., Chen, P. J., Miao, Z. & Liu, D. R. Programmable m6A modification of cellular RNAs with a Cas13-directed methyltransferase. Nat. Biotechnol. 38, 1431–1440 (2020).
Google Scholar
Xiao, W. et al. Nuclear m6A reader YTHDC1 regulates mRNA splicing. Mol. Cell 61, 507–519 (2016).
Google Scholar
Rees, H. A. & Liu, D. R. Base editing: precision chemistry on the genome and transcriptome of living cells. Nat. Rev. Genet. 19, 770–788 (2018).
Google Scholar
Marina, R. J., Brannan, K. W., Dong, K. D., Yee, B. A. & Yeo, G. W. Evaluation of engineered CRISPR-cas-mediated systems for site-specific RNA editing. Cell Rep. 33, 108350 (2020).
Google Scholar
Qu, L. et al. Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs. Nat. Biotechnol. 37, 1059–1069 (2019).
Google Scholar
Cox, D. B. T. et al. RNA editing with CRISPR–Cas13. Science 358, 1019–1027 (2017).
Google Scholar
Rauch, S. et al. Programmable RNA-guided RNA effector proteins built from human parts. Cell 178, 122–134.e12 (2019).
Google Scholar
Abudayyeh, O. O. et al. A cytosine deaminase for programmable single-base RNA editing. Science 365, 382–386 (2019).
Google Scholar
Salzman, J. Circular RNA expression: its potential regulation and function. Trends Genet. 32, 309–316 (2016).
Google Scholar
Lasda, E. & Parker, R. Circular RNAs: diversity of form and function. RNA 20, 1829–1842 (2014).
Google Scholar
Akhter, R. Circular RNA and Alzheimer’s disease. Adv. Exp. Med. Biol. 1087, 239–243 (2018).
Google Scholar
Altesha, M.-A., Ni, T., Khan, A., Liu, K. & Zheng, X. Circular RNA in cardiovascular disease. J. Cell Physiol. 234, 5588–5600 (2019).
Google Scholar
Han, B., Chao, J. & Yao, H. Circular RNA and its mechanisms in disease: from the bench to the clinic. Pharmacol. Ther. 187, 31–44 (2018).
Google Scholar
Prats, A.-C. et al. Circular RNA, the key for translation. Int. J. Mol. Sci. 21, 8591 (2020).
Google Scholar
Legnini, I. et al. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis. Mol. Cell 66, 22–37.e9 (2017).
Google Scholar
Pamudurti, N. R. et al. Translation of circRNAs. Mol. Cell 66, 9–21.e7 (2017).
Google Scholar
Litke, J. L. & Jaffrey, S. R. Highly efficient expression of circular RNA aptamers in cells using autocatalytic transcripts. Nat. Biotechnol. 37, 667–675 (2019).
Google Scholar
Wesselhoeft, R. A., Kowalski, P. S. & Anderson, D. G. Engineering circular RNA for potent and stable translation in eukaryotic cells. Nat. Commun. 9, 2629 (2018).
Google Scholar
Meganck, R. M. et al. Engineering highly efficient backsplicing and translation of synthetic circRNAs. Mol. Ther. Nucleic Acids 23, 821–834 (2021).
Google Scholar
Paige, J. S., Wu, K. Y. & Jaffrey, S. R. RNA mimics of green fluorescent protein. Science 333, 642–646 (2011).
Google Scholar
Rossbach, O. Artificial circular RNA sponges targeting microRNAs as a novel tool in molecular biology. Mol. Ther. Nucleic Acids 17, 452–454 (2019).
Google Scholar
Jost, I. et al. Functional sequestration of microRNA-122 from hepatitis C virus by circular RNA sponges. RNA Biol. 15, 1032–1039 (2018).
Google Scholar
Blight, K. J., McKeating, J. A. & Rice, C. M. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 76, 13001–13014 (2002).
Google Scholar
Schreiner, S., Didio, A., Hung, L.-H. & Bindereif, A. Design and application of circular RNAs with protein-sponge function. Nucleic Acids Res. 48, 12326–12335 (2020).
Google Scholar
Li, X., Yang, L. & Chen, L.-L. The biogenesis, functions, and challenges of circular RNAs. Mol. Cell 71, 428–442 (2018).
Google Scholar
Delebecque, C. J., Lindner, A. B., Silver, P. A. & Aldaye, F. A. Organization of intracellular reactions with rationally designed RNA assemblies. Science 333, 470–474 (2011).
Google Scholar
Sachdeva, G., Garg, A., Godding, D., Way, J. C. & Silver, P. A. In vivo co-localization of enzymes on RNA scaffolds increases metabolic production in a geometrically dependent manner. Nucleic Acids Res. 42, 9493–9503 (2014).
Google Scholar
Shibata, T. et al. Protein-driven RNA nanostructured devices that function in vitro and control mammalian cell fate. Nat. Commun. 8, 540 (2017).
Google Scholar
WHO. WHO coronavirus (COVID-19) dashboard with vaccination data. World Health Organization https://covid19.who.int/info (2020).
Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N. Engl. J. Med. 383, 2603–2615 (2020).
Google Scholar
Corbett, K. S. et al. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature 586, 567–571 (2020).
Google Scholar
Slaoui, M. & Hepburn, M. Developing safe and effective covid vaccines — Operation Warp Speed’s strategy and approach. N. Engl. J. Med. 383, 1701–1703 (2020).
Google Scholar
Bell, J. Moderna founder’s next big play in RNA raises $440M. BioPharma Dive https://www.biopharmadive.com/news/laronde-endless-rna-series-b-flagship-moderna/605740/ (2021).
Bell, J. Venture capital pours more money into RNA medicines with the launch of Replicate. BioPharma Dive https://www.biopharmadive.com/news/replicate-launch-rna-ehlers-apple-tree/606210/ (2021).
Al Idrus, A. Shape builds out RNA editing tech with a major $112M funding boost. FierceBiotech https://www.fiercebiotech.com/biotech/shape-therapeutics-reels-112m-to-spur-rna-editing-tech (2021).
Baek, M. et al. Accurate prediction of protein structures and interactions using a three-track neural network. Science 373, 871–876 (2021).
Google Scholar
Senior, A. W. et al. Improved protein structure prediction using potentials from deep learning. Nature 577, 706–710 (2020).
Google Scholar
Kuhlman, B. & Bradley, P. Advances in protein structure prediction and design. Nat. Rev. Mol. Cell Biol. 20, 681–697 (2019).
Google Scholar
Langan, R. A. et al. De novo design of bioactive protein switches. Nature 572, 205–210 (2019).
Google Scholar
Zhang, K. et al. Cryo-EM structure of a 40 kDa SAM-IV riboswitch RNA at 3.7 Å resolution. Nat. Commun. 10, 5511 (2019).
Google Scholar
Mustoe, A. M., Lama, N. N., Irving, P. S., Olson, S. W. & Weeks, K. M. RNA base-pairing complexity in living cells visualized by correlated chemical probing. Proc. Natl Acad. Sci. USA 116, 24574–24582 (2019).
Google Scholar
Yesselman, J. D. et al. Computational design of three-dimensional RNA structure and function. Nat. Nanotechnol. 14, 866–873 (2019).
Google Scholar
Watkins, A. M., Rangan, R. & Das, R. FARFAR2: improved de novo Rosetta prediction of complex global RNA folds. Structure 28, 963–976.e6 (2020).
Google Scholar
Townshend, R. J. L. et al. Geometric deep learning of RNA structure. Science 373, 1047–1051 (2021).
Google Scholar
Rosa, S. S., Prazeres, D. M. F., Azevedo, A. M. & Marques, M. P. C. mRNA vaccines manufacturing: challenges and bottlenecks. Vaccine 39, 2190–2200 (2021).
Google Scholar
Shi, H. et al. Bias in RNA-seq library preparation: current challenges and solutions. Biomed. Res. Int. 2021, 6647597 (2021).
Google Scholar
Yu, A.-M., Choi, Y. H. & Tu, M.-J. RNA drugs and RNA targets for small molecules: principles, progress, and challenges. Pharmacol. Rev. 72, 862–898 (2020).
Google Scholar
Schlick, T. & Pyle, A. M. Opportunities and challenges in RNA structural modeling and design. Biophysical J. 113, 225–234 (2017).
Google Scholar
Potter, K., Cremona, N. & Wise, J. A. in Encyclopedia of Biological Chemistry 2nd edn (eds Lennarz, W. J. & Lane, M. D.) 59–64 (Academic, 2013).
Wilkinson, M. E., Charenton, C. & Nagai, K. RNA splicing by the spliceosome. Annu. Rev. Biochem. 89, 359–388 (2020).
Google Scholar
Chen, L.-L. The biogenesis and emerging roles of circular RNAs. Nat. Rev. Mol. Cell Biol. 17, 205–211 (2016).
Google Scholar
Zhang, X. et al. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway. Mol. Cancer 18, 20 (2019).
Google Scholar
Cesana, M. et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147, 358–369 (2011).
Google Scholar
Merkle, T. et al. Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides. Nat. Biotechnol. 37, 133–138 (2019).
Google Scholar
